Detail akcie Biotec Pharmacon online

Business Summary: Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Arcticzymes Technologies ASA revenues decreased 13% to NOK118.9M. Net income applicable to common stockholders decreased 43% to NOK18.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Intangible Amortisation increase from NOK194K to NOK686K (expense).